REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.

Pilette C, Canonica GW, Chaudhuri R, Chupp G, Lee FE, Lee JK, Almonacid C, Welte T, Alfonso-Cristancho R, Jakes RW, Maxwell A, Price RG, Howarth P

Open source

DOI
10.1016/j.jaip.2022.05.042
Published
2022 Oct
Container
The journal of allergy and clinical immunology. In practice
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaip.2022.05.042,
  title = {REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.},
  author = {Pilette C and Canonica GW and Chaudhuri R and Chupp G and Lee FE and Lee JK and Almonacid C and Welte T and Alfonso-Cristancho R and Jakes RW and Maxwell A and Price RG and Howarth P},
  year = {2022},
  journal = {The journal of allergy and clinical immunology. In practice},
  doi = {10.1016/j.jaip.2022.05.042},
  url = {https://doi.org/10.1016/j.jaip.2022.05.042}
}

RIS

TY  - JOUR
TI  - REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.
AU  - Pilette C
AU  - Canonica GW
AU  - Chaudhuri R
AU  - Chupp G
AU  - Lee FE
AU  - Lee JK
AU  - Almonacid C
AU  - Welte T
AU  - Alfonso-Cristancho R
AU  - Jakes RW
AU  - Maxwell A
AU  - Price RG
AU  - Howarth P
PY  - 2022
JO  - The journal of allergy and clinical immunology. In practice
DO  - 10.1016/j.jaip.2022.05.042
UR  - https://doi.org/10.1016/j.jaip.2022.05.042
ER  - 

APA

C, P., GW, C., R, C., G, C., FE, L., JK, L., C, A., T, W., R, A., RW, J., A, M., RG, P., & P, H. (2022). REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2022.05.042

Source records